BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 10910054)

  • 1. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.
    Hanna IH; Dawling S; Roodi N; Guengerich FP; Parl FF
    Cancer Res; 2000 Jul; 60(13):3440-4. PubMed ID: 10910054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic properties of polymorphic human cytochrome P450 1B1 variants.
    Shimada T; Watanabe J; Kawajiri K; Sutter TR; Guengerich FP; Gillam EM; Inoue K
    Carcinogenesis; 1999 Aug; 20(8):1607-13. PubMed ID: 10426814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.
    Dawling S; Roodi N; Mernaugh RL; Wang X; Parl FF
    Cancer Res; 2001 Sep; 61(18):6716-22. PubMed ID: 11559542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by human CYP1B1 genetic variants.
    Han JF; He XY; Herrington JS; White LA; Zhang JF; Hong JY
    Drug Metab Dispos; 2008 Apr; 36(4):745-52. PubMed ID: 18227148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1.
    Dawling S; Roodi N; Parl FF
    Cancer Res; 2003 Jun; 63(12):3127-32. PubMed ID: 12810639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH- and hydroperoxide-supported 17beta-estradiol hydroxylation catalyzed by a variant form (432L, 453S) of human cytochrome P450 1B1.
    Spink DC; Spink BC; Zhuo X; Hussain MM; Gierthy JF; Ding X
    J Steroid Biochem Mol Biol; 2000 Sep; 74(1-2):11-8. PubMed ID: 11074351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and functional analysis of two common human cytochrome P450 1B1 variants.
    McLellan RA; Oscarson M; Hidestrand M; Leidvik B; Jonsson E; Otter C; Ingelman-Sundberg M
    Arch Biochem Biophys; 2000 Jun; 378(1):175-81. PubMed ID: 10871058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol.
    Badawi AF; Cavalieri EL; Rogan EG
    Metabolism; 2001 Sep; 50(9):1001-3. PubMed ID: 11555828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the NADPH-dependent metabolism of 17beta-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome P450 3A4 and 3A5.
    Lee AJ; Kosh JW; Conney AH; Zhu BT
    J Pharmacol Exp Ther; 2001 Aug; 298(2):420-32. PubMed ID: 11454902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in P450 CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol.
    Li DN; Seidel A; Pritchard MP; Wolf CR; Friedberg T
    Pharmacogenetics; 2000 Jun; 10(4):343-53. PubMed ID: 10862525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated 4-hydroxylation of estradiol by hamster kidney microsomes: a potential pathway of metabolic activation of estrogens.
    Weisz J; Bui QD; Roy D; Liehr JG
    Endocrinology; 1992 Aug; 131(2):655-61. PubMed ID: 1386303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 1B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation.
    Belous AR; Hachey DL; Dawling S; Roodi N; Parl FF
    Cancer Res; 2007 Jan; 67(2):812-7. PubMed ID: 17234793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential action of phase I and II enzymes cytochrome p450 1B1 and glutathione S-transferase P1 in mammary estrogen metabolism.
    Hachey DL; Dawling S; Roodi N; Parl FF
    Cancer Res; 2003 Dec; 63(23):8492-9. PubMed ID: 14679015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.
    Hayes CL; Spink DC; Spink BC; Cao JQ; Walker NJ; Sutter TR
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9776-81. PubMed ID: 8790407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of recombinant-expressed cytochrome P450 2C3 from Escherichia coli: 2C3 encodes the 6 beta-hydroxylase deficient form of P450 3b.
    Richardson TH; Hsu MH; Kronbach T; Barnes HJ; Chan G; Waterman MR; Kemper B; Johnson EF
    Arch Biochem Biophys; 1993 Jan; 300(1):510-6. PubMed ID: 8380971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regioselective 2-hydroxylation of 17beta-estradiol by rat cytochrome P4501B1.
    Rahman M; Hayes Sutter C; Emmert GL; Sutter TR
    Toxicol Appl Pharmacol; 2006 Nov; 216(3):469-78. PubMed ID: 16893557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms.
    Lee AJ; Cai MX; Thomas PE; Conney AH; Zhu BT
    Endocrinology; 2003 Aug; 144(8):3382-98. PubMed ID: 12865317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
    Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
    Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer.
    Watanabe J; Shimada T; Gillam EM; Ikuta T; Suemasu K; Higashi Y; Gotoh O; Kawajiri K
    Pharmacogenetics; 2000 Feb; 10(1):25-33. PubMed ID: 10739169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of CYP1A1 polymorphisms with differential metabolic activation of 17beta-estradiol and estrone.
    Kisselev P; Schunck WH; Roots I; Schwarz D
    Cancer Res; 2005 Apr; 65(7):2972-8. PubMed ID: 15805301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.